The End of Pharmacy Sticker Shock: How Epic's New Marketplace Upends Drug Pricing

VERONA, WI – October 15, 2026 — For millions of Americans, the most anxiety-inducing part of a medical diagnosis isn't the treatment plan; it is the moment the pharmacist rings up the prescription. More than 40% of adults in the United States report skipping, rationing, or abandoning their medications entirely because they simply cannot afford the out-of-pocket costs at the counter. Now, the largest electronic health record (EHR) provider in the country is attempting to solve this crisis by pulling back the curtain on drug pricing before the patient ever leaves the exam room.

Epic Systems has announced the summer 2027 launch of Prescription Marketplace, a tool designed to let clinicians and patients compare pharmacy cash prices against insurance copays in real-time. By embedding direct-to-consumer cash pricing natively into the physician's prescribing workflow, the Verona-based software giant is taking aim at the opaque pricing structures that have defined American healthcare for decades.

With Epic currently supporting more than 3,500 hospitals and connecting over 195 million patients via its MyChart portal, the sheer scale of this rollout guarantees a seismic shift in how prescription drugs are bought and sold. But the implications of this technology extend far beyond a simple price comparison tool. It represents a direct challenge to traditional pharmacy benefit managers, a new frontier for Big Tech and Big Pharma, and a fundamental shift in the responsibilities of the frontline physician.

Bypassing the Middleman

To understand the disruptive potential of the Prescription Marketplace, one must understand the entrenched system it seeks to bypass. Traditionally, Pharmacy Benefit Managers (PBMs) act as the middlemen of the drug supply chain. They manage prescription benefits for health plans, negotiating rebates with pharmaceutical manufacturers and dictating the formularies and copay tiers for insured patients.

This model has come under intense scrutiny from federal regulators and healthcare economists for its opacity. Often, a patient's insurance copay for a medication is significantly higher than what the drug would cost if purchased outright with cash. However, because the system defaults to processing through insurance, neither the doctor nor the patient is aware of this discrepancy until it is too late.

Epic's new feature brings cash-pay disruptors directly to the point of care, effectively undermining the PBM rebate volume. If a patient chooses a cash option that bypasses their insurance, the PBM loses its administrative cut of that transaction.

"This will give patients transparency," said Mark Cuban, co-founder of Mark Cuban Cost Plus Drugs, one of the primary pharmacies collaborating with Epic to build the feature. "If someone's insurance says a prescription costs $500 but they can buy the exact same drug for $100 at CostPlusDrugs.com, they should know that before they leave the doctor's office."

By exposing these cash-pay alternatives at the exact moment a prescription is written, Epic is forcing a level of transparency that traditional PBMs have long resisted, potentially driving deflationary pressure across outpatient prescription drug costs at an unprecedented scale.

The Consumer Dilemma at the Doctor's Office

While the promise of cheaper medications is a clear victory for consumers, the introduction of cash pricing at the point of care introduces a complex new variable into the patient experience: the deductible dilemma.

Typically, cash payments made outside of an insurance plan do not count toward an individual's health insurance deductible or annual out-of-pocket maximum. For patients enrolled in high-deductible health plans, choosing a lower cash price might save them $40 today, but it could delay them from reaching their deductible threshold, after which their insurance would cover the lion's share of their medical costs.

Healthcare economists note that this creates a challenging behavioral economics scenario. Patients will be forced to weigh immediate, tangible savings against long-term, abstract insurance accruals. The introduction of cash price options alongside copays will require clear, intuitive communication within the EHR interface to prevent widespread confusion.

Despite this hurdle, the overarching benefit of reducing prescription abandonment cannot be overstated. Epic's existing Real-Time Prescription Benefit tool, which currently shows physicians insurance copays alongside generic alternatives, helped patients save an estimated $250 million in 2025. By adding cash prices to this interface, the financial savings—and the corresponding improvements in medication adherence—are expected to multiply.

Big Tech and Big Pharma at the EHR Gateway

The partnerships fueling Prescription Marketplace reveal a fascinating strategic alignment between major retail players, Big Tech, and pharmaceutical manufacturers. Amazon Pharmacy, Costco, and Eli Lilly have all secured a seat at the table, ensuring their direct-to-consumer storefronts are embedded directly into the clinical workflow.

For a pharmaceutical giant like Eli Lilly, partnering with an EHR platform is a strategic masterstroke. Through its LillyDirect platform, the manufacturer can present its cash-pay options directly to prescribers, bypassing PBM formularies that might heavily favor a competitor's drug or mandate arduous step-therapy protocols.

"Patients shouldn't have to navigate a complicated healthcare system on their own to understand their options for filling a prescription," said Jen Mazur, general manager of U.S. LillyDirect at Eli Lilly and Company. "Giving patients and their healthcare providers greater visibility into pharmacy options and costs at the point of care is another important step toward reducing friction in the healthcare experience."

Similarly, Amazon Pharmacy has been working with Epic since early 2025 to shape this development, recognizing that point-of-sale influence is the ultimate prize in healthcare retail.

"Getting medications should be simple, transparent, and convenient," noted Tanvi Patel, vice president and general manager of Amazon Pharmacy. "Customers deserve to know what their medications will cost, choose whether to use insurance or pay cash, and get their prescriptions in a way that works for them."

While Epic has stated that any licensed pharmacy will be eligible to share its cash prices on the platform, the technical reality may paint a different picture. Feeding real-time pricing data and inventory levels into a massive EHR network requires robust API integration and sophisticated IT infrastructure. Health informatics specialists warn that while massive chains and tech-forward startups will integrate seamlessly, independent community pharmacies may struggle to meet the technical and operational criteria required to compete on this new digital shelf.

The Clinical Workflow: Empowerment or Burden?

Ultimately, the success of Prescription Marketplace hinges on the very people who will operate it: the physicians.

Adding multi-pharmacy price comparisons at the point of prescribing carries the inherent risk of increasing administrative burden. In a standard 15-minute primary care visit, doctors cannot afford to spend five minutes acting as financial advisors, navigating complex UI screens to explain the nuances of cash versus insurance to their patients. If the tool induces decision fatigue or clutters the interface, adoption will stall.

However, early indicators suggest the tool may actually streamline clinic operations. By identifying the most affordable option upfront, providers can drastically reduce the volume of call-backs from frustrated patients stranded at the pharmacy counter. Furthermore, sidestepping insurance for a cheaper cash option can eliminate the need for time-consuming prior authorizations.

"Having integrated access to clear and transparent pricing enables patients and prescribers to make better decisions, reduce abandonment at the pharmacy counter, and close care gaps," explained Ricky Li, assistant vice president at Costco.

If the interface is intuitive, the trade-off for physicians is clear: a few extra seconds spent selecting a pharmacy in the exam room could save hours of administrative triage later in the week. The delicate balance of usability, cost transparency, and workflow integration will be a primary focus when Amazon Pharmacy, Costco, and Eli Lilly join Epic for a panel discussion on medication affordability at the Open@Epic conference in Verona on Wednesday, October 21.